ATLANTA, April 18, 2023 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Alvotech (“Alvotech” or the “Company”) ALVO Federal securities laws complied with. On April 13, 2023, Alvotech announced that the FDA “issued a Complete Response Letter (“CRL”) for Alvotech’s biologics regulatory submission” identifying certain deficiencies and stating that the FDA requires that the deficiencies be “satisfactorily addressed.” remedied before the application can be approved.” Following the news, the company’s stock price fell.

If you have purchased Alvotech stock and suffered a loss on that investment, please contact Corey Holzer, Esq. at holzer@holzerlaw.com or Joshua Karr, Esq. atjkarr@holzerlaw.comcall our toll free number at (888) 508-6832 or visit our website at https://holzerlaw.com/case/alvotech/ to discuss your legal rights.

Holzer & Holzer, LLC, an ISS Top-Rated Securities Litigation Law Firm for 2021 and 2022, is dedicated in its practice to vigorously representing shareholders and investors in litigation across the country, including shareholder class actions and derivatives disputes. Since its inception in 2000, Holzer & Holzer’s attorneys have played a critical role in recovering hundreds of millions of dollars for shareholders who have been victims of fraud and other corporate wrongdoing. More information about the law firm can be found on their website, www.holzerlaw.com, and on request from the company. Holzer & Holzer, LLC has paid for the distribution of this promotional communication and Corey Holzer is the attorney responsible for its content.

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll free)
holzer@holzerlaw.com